SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-05-037306
Filing Date
2005-08-08
Accepted
2005-08-08 17:12:41
Documents
5
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a05-12716_110q.htm 10-Q 712738
2 EX-10.48 a05-12716_1ex10d48.htm EX-10.48 262921
3 EX-31.1 a05-12716_1ex31d1.htm EX-31.1 13997
4 EX-31.2 a05-12716_1ex31d2.htm EX-31.2 13984
5 EX-32.1 a05-12716_1ex32d1.htm EX-32.1 6365
  Complete submission text file 0001104659-05-037306.txt   1011441
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19700 | Film No.: 051006560
SIC: 2834 Pharmaceutical Preparations